COVID-19 hos børn ogog ungeunge

Astrid Blicher Schelde; Katrine Finderup Nielsen; Ulrikka Nygaard; Marie-Louise von Linstow; Laura Espenhain; Anders Koch

COVID-19 hos børn ogog ungeunge

Astrid Blicher Schelde, Katrine Finderup Nielsen, Ulrikka Nygaard, Marie-Louise von Linstow, Laura Espenhain, Anders Koch

Publikation: Bidrag til tidsskrift › Review › peer review

28 Downloads (Pure)

Abstract

Children and adolescents infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are usually asymptomatic or have mild coronavirus disease (COVID-19) with low rates of hospitalization and death. Multisystem inflammatory syndrome in children (MIS-C) is a rare and severe complication of SARS-CoV-2 infection. This paper reviews an excerpt of the literature on disease burden and complications following COVID-19 in children and adolescents aged 0-17 years, in addition to the effects and adverse drug reactions of BNT162b2 and mRNA-1273 vaccinations among children and adolescents aged 5-17 years.

Bidragets oversatte titel	COVID-19 among children and adolescents
Originalsprog	Dansk
Artikelnummer	V11210858
Tidsskrift	Ugeskrift for Laeger
Vol/bind	184
Udgave nummer	9
Antal sider	6
ISSN	0041-5782
Status	Udgivet - 2022

Emneord

Adolescent
BNT162 Vaccine
COVID-19/complications
Child
Child, Preschool
Hospitalization
Humans
Infant
Infant, Newborn
SARS-CoV-2
Systemic Inflammatory Response Syndrome

Adgang til dokumentet

FulltextForlagets udgivne version, 183 KBLicens: CC BY-NC-ND

https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-03/v11210858_web.pdfLicens: CC BY-NC-ND

Biblioteksadgang?

Tjek tilgængelighed hos det Kgl. Bibliotek

Citationsformater

@article{d6765a93ea044b1dbec783a490263165,

title = "COVID-19 hos b{\o}rn ogog ungeunge",

abstract = "Children and adolescents infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are usually asymptomatic or have mild coronavirus disease (COVID-19) with low rates of hospitalization and death. Multisystem inflammatory syndrome in children (MIS-C) is a rare and severe complication of SARS-CoV-2 infection. This paper reviews an excerpt of the literature on disease burden and complications following COVID-19 in children and adolescents aged 0-17 years, in addition to the effects and adverse drug reactions of BNT162b2 and mRNA-1273 vaccinations among children and adolescents aged 5-17 years.",

keywords = "Adolescent, BNT162 Vaccine, COVID-19/complications, Child, Child, Preschool, Hospitalization, Humans, Infant, Infant, Newborn, SARS-CoV-2, Systemic Inflammatory Response Syndrome",

author = "Schelde, {Astrid Blicher} and Nielsen, {Katrine Finderup} and Ulrikka Nygaard and {von Linstow}, Marie-Louise and Laura Espenhain and Anders Koch",

year = "2022",

language = "Dansk",

volume = "184",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "9",

}

TY - JOUR

T1 - COVID-19 hos børn ogog ungeunge

AU - Schelde, Astrid Blicher

AU - Nielsen, Katrine Finderup

AU - Nygaard, Ulrikka

AU - von Linstow, Marie-Louise

AU - Espenhain, Laura

AU - Koch, Anders

PY - 2022

Y1 - 2022

N2 - Children and adolescents infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are usually asymptomatic or have mild coronavirus disease (COVID-19) with low rates of hospitalization and death. Multisystem inflammatory syndrome in children (MIS-C) is a rare and severe complication of SARS-CoV-2 infection. This paper reviews an excerpt of the literature on disease burden and complications following COVID-19 in children and adolescents aged 0-17 years, in addition to the effects and adverse drug reactions of BNT162b2 and mRNA-1273 vaccinations among children and adolescents aged 5-17 years.

AB - Children and adolescents infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are usually asymptomatic or have mild coronavirus disease (COVID-19) with low rates of hospitalization and death. Multisystem inflammatory syndrome in children (MIS-C) is a rare and severe complication of SARS-CoV-2 infection. This paper reviews an excerpt of the literature on disease burden and complications following COVID-19 in children and adolescents aged 0-17 years, in addition to the effects and adverse drug reactions of BNT162b2 and mRNA-1273 vaccinations among children and adolescents aged 5-17 years.

KW - Adolescent

KW - BNT162 Vaccine

KW - COVID-19/complications

KW - Child

KW - Child, Preschool

KW - Hospitalization

KW - Humans

KW - Infant

KW - Infant, Newborn

KW - SARS-CoV-2

KW - Systemic Inflammatory Response Syndrome

M3 - Review

C2 - 35244020

SN - 0041-5782

VL - 184

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 9

M1 - V11210858

ER -